Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 194
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Targeting the brain with Curcumin: Can we treat Chronic Traumatic Encephalopathy?

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory...

How do chemical exposures trigger autoimmune diseases?

The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

Can a crocodile cure your ills? Testing the Crocodylus Apothecary Hypothesis

Why did alchemists hang crocodiles from the ceilings of their shops? Why did ancient Egyptians worship crocodiles...

Backer Badge Funded